Shanghai Henlius Biotech Balance Sheet Health
Financial Health criteria checks 3/6
Shanghai Henlius Biotech has a total shareholder equity of CN¥2.2B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 174.2%. Its total assets and total liabilities are CN¥9.9B and CN¥7.7B respectively. Shanghai Henlius Biotech's EBIT is CN¥631.7M making its interest coverage ratio 6.2. It has cash and short-term investments of CN¥1.0B.
Key information
174.2%
Debt to equity ratio
CN¥3.82b
Debt
Interest coverage ratio | 6.2x |
Cash | CN¥1.01b |
Equity | CN¥2.19b |
Total liabilities | CN¥7.71b |
Total assets | CN¥9.90b |
Recent financial health updates
Here's Why Shanghai Henlius Biotech (HKG:2696) Is Weighed Down By Its Debt Load
Dec 31Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 18Shanghai Henlius Biotech (HKG:2696) Has Debt But No Earnings; Should You Worry?
May 31Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 22Recent updates
Shanghai Henlius Biotech, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Mar 25Shanghai Henlius Biotech, Inc.'s (HKG:2696) Price Is Right But Growth Is Lacking
Mar 10Here's Why Shanghai Henlius Biotech (HKG:2696) Is Weighed Down By Its Debt Load
Dec 31The Strong Earnings Posted By Shanghai Henlius Biotech (HKG:2696) Are A Good Indication Of The Strength Of The Business
Nov 25Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 18Improved Revenues Required Before Shanghai Henlius Biotech, Inc. (HKG:2696) Shares Find Their Feet
Aug 03Shanghai Henlius Biotech (HKG:2696) Has Debt But No Earnings; Should You Worry?
May 31Need To Know: Analysts Are Much More Bullish On Shanghai Henlius Biotech, Inc. (HKG:2696) Revenues
Apr 06Is Shanghai Henlius Biotech (HKG:2696) Using Too Much Debt?
Sep 22Financial Position Analysis
Short Term Liabilities: 2696's short term assets (CN¥2.7B) do not cover its short term liabilities (CN¥5.1B).
Long Term Liabilities: 2696's short term assets (CN¥2.7B) exceed its long term liabilities (CN¥2.6B).
Debt to Equity History and Analysis
Debt Level: 2696's net debt to equity ratio (128.2%) is considered high.
Reducing Debt: 2696's debt to equity ratio has increased from 18.6% to 174.2% over the past 5 years.
Debt Coverage: 2696's debt is well covered by operating cash flow (27.4%).
Interest Coverage: 2696's interest payments on its debt are well covered by EBIT (6.2x coverage).